Other languages Centogene N.V.

Equities

CNTG

NL0014040206

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-26 pm EDT			5-day change	1st Jan Change
0.4889 ^USD	+1.88%		+7.24%	-59.26%

Apr. 02	Centogene Gets Nasdaq Noncompliance Notice	MT
Mar. 19	Centogene, Takeda Pharmaceutical Collaborate on Lysosomal Storage Disorders Diagnostics	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Centogene, Takeda Pharmaceutical Collaborate on Lysosomal Storage Disorders Diagnostics	Mar. 19
Centogene N.V. Announces the Extension of an Ongoing Partnership with Takeda to Continue Providing Access to Genetic Testing for Patients with Lysosomal Storage Disorders	Mar. 19
Centogene Explores Strategic Alternatives	Feb. 27
Centogene N.V. and the Laboratory of Human Genetics of Infectious Diseases At Institut Imagine Announce Rare Disease Research Collaboration	Jan. 25
Centogene N.V. and The Michael J. Fox Foundation for Parkinson's Research Announces Research Project to Validate Genetic Risk Factors of Parkinson's Disease Using Multiomics	Jan. 23
Centogene N.V. Provides Earnings Guidance for the Full Year 2023	Jan. 18
Centogene N.V. Announces Changes to Supervisory Board	Dec. 18
Centogene N.V.'s Frontotemporal Dementia Genetic Study, EFRONT, Reaches Initial Patient Enrollment Milestone	Dec. 13
Centogene N.V. and Lifera Complete Strategic Joint Venture Transaction	Nov. 28
Centogene N.V. Announces the Discovery of A New Form of Early-Onset Dystonia and Parkinsonism	Nov. 14
Centogene N.V. Expands Multiomic Diagnostic Portfolio with Newly-Launched Transcriptomic Offering	23-10-10
Flemming Ornskov Decides to Step Down from His Role as a Member of the Supervisory Board of Centogene	23-10-06
Centogene N.V. Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-07
Centogene N.V. Reaffirms Revenue Guidance for the Year 2023	23-09-07
Upcoming Payrolls Report Lifts Exchange-Traded Funds, Equity Futures Premarket Friday	23-09-01
Centogene N.V. Announces Publication Establishing Lyso-Gb1 as A Predictive Biomarker for Gaucher Disease Patients	23-09-01
Centogene Receives Non-Compliance Notice From Nasdaq	23-09-01
Centogene N.V. Announces Resignation of Berndt Modig from Supervisory Board	23-08-18
Centogene Regains Compliance With Nasdaq Listing Rules	23-07-14
Centogene Biodatabank Reveals Unique Genetic Variants in World's Largest Niemann-Pick Type C1 Disease Cohort	23-07-12

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Centogene N.V.

Equities

CNTG

NL0014040206

Other languages

Filters